Study Title: A Single Arm Phase II Study of Palbociclib in Combination with Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016

• Status: Completed
• Participating Sites:
  • University of Illinois Cancer Center
  • Michigan State University
  • Masonic Cancer Center, University of Minnesota
  • Fred & Pamela Buffett Cancer Center (University of Nebraska)
  • Penn State Cancer Institute
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT02668666
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster Session: 2021 ASCO Annual Meeting
  • Poster Session (Biologic Correlates): 2021 ASCO Annual Meeting
  • Poster Session: 2019 San Antonio Breast Cancer Symposium